Your bridge to translation success
End-to-end preclinical strategy, CRO selection, and quality oversight, so your IND/IMPD is right the first time.
01
02
03
Expertise in oncology, anti-infectives, vaccines, and complex generics.
04
Strategy first. We write the plan, not just the PO.
The right lab, the first time. CRO matchmaking with due diligence.
Relentless quality. GxP audits, data integrity checks, AAALAC awareness.
Transparent budgets & timelines. No surprises, no sunk-cost traps.
Leaders, not intermediaries
Programs are guided by veteran scientists and former R&D heads.
Network, not noise
Curated GLP/GMP partners with track records in complex modalities.
Quality baked in
ICH, OECD, and AAALAC expectations integrated from day one.
India fluency
Local know-how on ethics, permits, export, sample flow, and compliance.
Regulatory Strategy & IND/IMPD Road-mapping
Preclinical Study Design & CRO Matchmaking
GLP Toxicology & Safety Pharmacology
DMPK/ADME & Bioanalytics
Chemistry, Manufacturing & Controls
Biologics & Vaccines (incl. NHP/Large Animal)
Medical Devices & Diagnostics
Program & Quality Oversight
Across the biopharma, biotech, and medical device ecosystem, our clients trust Sraman Life Sciences to deliver precision-driven regulatory and preclinical solutions. From early discovery to IND/IMPD submission, we’ve partnered with organizations that value scientific integrity, data transparency, and right-first-time execution.
Recent insights, case studies, and scientific updates that shape the future of preclinical and regulatory science.
